Depression and anxiety affect approximately 40% of adults with chronic pain, according to a massive new systematic review and ...
2d
MedPage Today on MSNChronic Pain Sufferers No Stranger to Depression and AnxietyAmong 347,468 individuals who had lived with persistent pain for over 3 months, clinical symptoms of depression and anxiety ...
Johnson & Johnson will stop late-stage studies of its experimental drug to treat major depressive disorder due to a lack of ...
Major depressive disorder with seasonal patterns, also known as seasonal affective disorder, causes symptoms similar to ...
Menopause can worsen symptoms of bipolar disorder. In rare cases, it may trigger bipolar disorder. Menopause is a factor when ...
Analysts do not believe the Phase III stumble for aticaprant will derail J&J’s broader neuroscience strategy, particularly ...
6d
PsyPost on MSNMetabolic signature of depression found in blood, revealing biological links to the disorderA large-scale study published in Molecular Psychiatry has uncovered a distinct pattern of biological changes in people with ...
1d
TipRanks on MSNMind Medicine’s (MNMD) Recent Achievements Boosting StockMind Medicine ($MNMD) announced its Q4 financials and indicated it is making strides in developing innovative treatments for ...
Analysts say the decision is a “big blow” to a once-promising class of brain therapies that include’s J&J’s aticaprant and a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results